Search

Your search keyword '"Imipramine chemistry"' showing total 98 results

Search Constraints

Start Over You searched for: Descriptor "Imipramine chemistry" Remove constraint Descriptor: "Imipramine chemistry"
98 results on '"Imipramine chemistry"'

Search Results

1. Molecular mechanism of EAG1 channel inhibition by imipramine binding to the PAS domain.

2. An Experimental and Theoretical Study of Laser Postionization of Femtosecond-Laser-Desorbed Drug Molecules.

3. Stimuli-responsive graphene-based hydrogel driven by disruption of triazine hydrophobic interactions.

4. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.

5. Degradation of imipramine by vacuum ultraviolet (VUV) system: Influencing parameters, mechanisms, and variation of acute toxicity.

6. Toward Higher Sensitivity in Quantitative MALDI Imaging Mass Spectrometry of CNS Drugs Using a Nonpolar Matrix.

7. Efficient degradation of imipramine by iron oxychloride-activated peroxymonosulfate process.

8. Inhibition of acid sphingomyelinase disrupts LYNUS signaling and triggers autophagy.

9. Super paramagnetic core-shells anchored onto silica grafted with C 8 /NH 2 nano-particles for ultrasound-assisted magnetic solid phase extraction of imipramine and desipramine from plasma.

10. The capacity and effectiveness of diosmectite and charcoal in trapping the compounds causing the most frequent intoxications in acute medicine: A comparative study.

11. Chromatographic studies of drug interactions with alpha 1 -acid glycoprotein by ultrafast affinity extraction and peak profiling.

12. Serotonergic and dopaminergic systems are implicated in antidepressant-like effects of chotosan, a Kampo formula, in mice.

13. High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania.

14. Membrane anchor of cytochrome P450 reductase suppresses the uncoupling of cytochrome P450.

15. [Production and assessing release of imipramine and magnesium from tablets].

16. Rapid LC-MS/MS method for determination of drotaverine in a bioequivalence study.

17. Comparative release studies of two cationic model drugs from different cellulose nanocrystal derivatives.

18. N-demethylation and N-oxidation of imipramine in rat thoracic aortic endothelial cells.

19. In silico study on the inhibitory interaction of drugs with wild-type CYP2D6.1 and the natural variant CYP2D6.17.

20. Evaluation of thermodynamic parameters of some amphiphilic drugs in presence of sugars at the cloud point.

21. Effect of inorganic salts on the clouding behavior of hydroxypropyl methyl cellulose in presence of amphiphilic drugs.

22. Determination of a novel TAZ modulator, 2-butyl-5-methyl-6-(pyridine-3-yl)-3-[2'-(1H-tetrazole-5-yl)-biphenyl-4-ylmethyl]-3H imidazo[4,5-b]pyridine] (TM-25659) in rat plasma by liquid chromatography-tandem mass spectrometry.

23. Micellization of mixtures of amphiphilic drugs and cationic surfactants: a detailed study.

24. Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.

25. Prediction of adverse events by in vivo gene expression profiling exemplified for phytopharmaceuticals containing salicylates and the antidepressant imipramine.

26. Pharmacophore modeling for hERG channel facilitation.

27. A spectrophotometric assay method for vanadium in biological and environmental samples using 2,4-dinitrophenylhydrazine with imipramine hydrochloride.

28. Aggregation behavior and interaction of an amphiphilic drug imipramine hydrochloride with cationic surfactant cetyltrimethylammonium bromide: light scattering studies.

29. Evaluation of the potential of surface enhancement Raman spectroscopy for detection of tricyclic psychotropic drugs. Case studies on imipramine and its metabolite.

30. (S)- and (R)-fluoxetine as native markers in mass spectrometry (MS) binding assays addressing the serotonin transporter.

31. Synthesis of 3,7-disubstituted imipramines by palladium-catalysed amination/cyclisation and evaluation of their inhibition of monoamine transporters.

32. Effects of pharmaceutical excipients on cloud points of amphiphilic drugs.

33. Matrix-assisted laser desorption mass spectrometry imaging for the examination of imipramine absorption by Straticell-RHE-EPI/001 an artificial model of the human epidermis.

34. Determination of a dipeptidyl peptidase IV agonist, β-aminoacyl containing thiazolidine derivatives (KR-66223) in rat plasma by liquid chromatography-tandem mass spectrometry.

35. Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns.

36. Determination of imipramine and trimipramine by capillary electrophoresis with electrochemiluminescence detection.

37. Molecular modeling and UV-vis spectroscopic studies on the mechanism of action of reversed chloroquine (RCQ).

38. Complexation behavior of gelatin with amphiphilic drug imipramine hydrochloride as studied by conductimetry, surface tensiometry and circular dichroism studies.

39. Regulation of serotonin transport in human platelets by tyrosine kinase Syk.

40. Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter.

41. Unusual spectral shifts of imipramine and carbamazepine drugs.

42. In vitro studies of DNA damage caused by tricyclic antidepressants: a role of peroxidase in the side effects of the drugs.

43. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.

44. Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin.

45. Evaluation of thermodynamic parameters of amphiphilic tricyclic antidepressant drug imipramine hydrochloride-additive systems at the cloud point.

46. Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter.

47. Binding and release studies of a cationic drug from a star-shaped four-arm poly(ethylene oxide)-b-poly(methacrylic acid).

48. Identification of novel allosteric nonpeptidergic inhibitors of the human cytomegalovirus-encoded chemokine receptor US28.

49. Optimization of salting-out taste-masking system for micro-beads containing drugs with high solubility.

50. Light scattering studies of amphiphilic drugs promethazine hydrochloride and imipramine hydrochloride in aqueous electrolyte solutions.

Catalog

Books, media, physical & digital resources